3 companies
argenx
Market Cap: €43.8b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€710.00
7D
5.9%
1Y
35.7%
Atenor
Market Cap: €100.5m
Operates as a real estate development company in Belgium, Hungary, Poland, the Netherlands, France, Portugal, Romania, Luxembourg, Germany, and the United Kingdom.
ATEB
€1.70
7D
0.6%
1Y
-41.4%
Recticel
Market Cap: €584.6m
An insulation company, provides thermal and thermo-acoustic solutions in Belgium, France, the Netherlands, Germany, Slovenia, other European Union countries, the United Kingdom, the United States, and internationally.
RECT
€10.14
7D
2.4%
1Y
-2.9%